How do I appeal a Wegovy insurance denial?

Request the written denial and the plan's GLP-1 clinical policy. File an internal appeal or PBM exception that documents your BMI, weight-related comorbidities, and any required step-therapy trials with dates and outcomes. A signed prescriber letter of medical necessity should match the chart.

Why was my GLP-1 denied if it is FDA-approved?

FDA approval means a drug may be marketed for labeled uses. Your plan still applies formulary, prior auth, BMI, and step-therapy rules. Those plan rules can be stricter than the label. Appeal by showing you meet the plan's written criteria or that an exception is medically required.

What is step therapy for weight-loss drugs?

The plan may require a trial of a preferred drug, often an older agent, before covering a GLP-1. An exception is appropriate when the preferred drug was tried and failed, caused harm, is contraindicated, or would be ineffective based on the prescriber's documented rationale.

Does BMI 27 with a comorbidity always get coverage?

No. Many commercial policies use BMI ≥30, a higher BMI, a longer lifestyle-program requirement, or a listed comorbidity set. Read the denial policy. If you meet the label but not the plan, ask for an exception with clinical reasons. Do not claim the plan must follow the label alone.

Should my doctor sign the letter?

A signed letter of medical necessity from the prescriber is the usual supporting document PBMs expect. Generate a draft here, then have the clinician edit facts, add chart details, and sign. Do not submit clinical claims the chart does not support.

Where do I submit a pharmacy GLP-1 appeal?

Often through the PBM such as CVS Caremark, Express Scripts, or OptumRx, or through CoverMyMeds, not only the medical-claims address on the EOB. The denial letter lists the correct channel. Employer plans may also allow a plan-level ERISA appeal.

What if Medicare denied Wegovy?

Original Medicare Part D coverage of anti-obesity drugs has been limited; some plan designs differ by year and product. Follow the Part D coverage determination or exception process on your plan's notice. Do not use commercial ERISA deadlines for Part D.

100% FreePharmacy / PANo login requiredAbout 4 minutes

GLP-1 denial appeal generator

Q: How long do I have to appeal a GLP-1 denial?

Use the deadline printed on your denial or EOB. Many ERISA employer plans allow up to 180 days for a first internal appeal under 29 CFR 2560.503-1. Medicare Part D and Medicaid use different clocks. Missing the deadline can end your appeal rights for that level.

Draft a GLP-1 prior auth appeal with BMI, comorbidities, and prior trials.

A GLP-1 denial appeal starts with the written denial letter and the plan's clinical policy or formulary rule. Most denials cite prior authorization, step therapy, BMI thresholds, or non-formulary status, and you can challenge them with documented BMI, comorbidities, and failed therapies mapped to the plan's own criteria. ERISA employer plans often allow up to 180 days for a first internal appeal under 29 CFR 2560.503-1; Medicare Part D and Medicaid use separate clocks printed on your notice.

100% free
No login required
Export & print

Loading generator…

Complete guide

How to appeal a GLP-1 insurance denial

Use the GLP-1 denial appeal generator above to draft your letter from your denial details, then have your prescriber review and sign it.

How this tool works

You enter denial facts from your EOB or denial letter — member ID, claim number, service, and the reason the payer gave.
AppealFlow drafts structured appeal language you can edit in the browser. Optional checkboxes add ERISA full-and-fair-review language, No Surprises Act references, or expedited-review requests when they fit your facts.
Export PDF or Word, keep a copy for your records, and file through the portal, fax, or mailing address on your notice before the deadline printed there.

Internal appeals ask the plan to reconsider its own adverse benefit determination. You are not debating fairness in general — you are showing why the decision failed the plan's medical policy, authorization rules, or billing edits.

Keep a single timeline document with denial date, appeal submission date, follow-up calls, and any additional information requests. This record supports state department complaints if the carrier misses required response times under 29 CFR 2560.503-1 or state analogs.

When clinical criteria are cited, request the plan medical policy the reviewer used. You may obtain it through member services or a written request. Compare each criterion to your chart note rather than quoting internet summaries.

Who this is for

Adults denied Wegovy, Zepbound, Saxenda, Ozempic, or Mounjaro for weight or diabetes-related use
People told to try older weight-loss drugs, diet programs, or metformin first
Prescribers who need a draft letter to review, edit, and sign
Members whose PBM denied a formulary exception or prior authorization for a GLP-1

This is not a coverage guarantee and not medical or legal advice
Medicare Part D and Medicaid have different clocks and forms than commercial plans

Step-by-step workflow

Step 1: Get the exact denial in writing
Ask for the denial letter, reason code, and the clinical policy or formulary rule used. A verbal “not covered” is not enough to appeal. Note the appeal deadline and whether the decision came from the PBM or the health plan.
Step 2: Match the denial type
Prior auth missing, BMI below plan threshold, comorbidity not documented, step therapy incomplete, and non-formulary are different arguments. Answer the specific reason on the letter instead of writing a generic “I need this drug” request.
Step 3: Document BMI, comorbidities, and prior trials
Include recent height/weight or BMI, diagnoses such as hypertension or type 2 diabetes, dates and outcomes of diet, exercise, and prior medications, plus contraindications if a required step drug is unsafe for you.
Step 4: Cite labeling and plan criteria, not slogans
FDA labeling for anti-obesity GLP-1s generally includes BMI ≥30, or BMI ≥27 with a weight-related condition. Your plan may set a higher bar. Quote the plan policy and show where you meet it, or explain why an exception is medically required.
Step 5: Request peer-to-peer or expedited review when appropriate
If the denial is urgent or clinically complex, ask the prescriber to request a peer-to-peer review with the PBM medical director. For situations where delay could seriously jeopardize health, request expedited review in writing and cite the plan's urgent-review rules.
Step 6: File on time through the right channel
Commercial ERISA plans often allow 180 days for a first internal appeal; many ACA plans use shorter windows printed on the EOB. Pharmacy denials may go through a PBM portal such as CoverMyMeds, Caremark, Express Scripts, or OptumRx. Keep fax confirmations or portal receipts.

Worked example: step therapy for Zepbound

Denial dated April 2, 2026 cites required trial of phentermine. You attach office notes showing 12 weeks ending January 2026 with blood pressure spike (ICD-10 I10). Your appeal requests a step-therapy exception and cites the plan's GLP-1 policy section named on the letter. File through the PBM portal listed on the EOB before the pharmacy determination deadline.

Appeal deadlines by plan type (reference)

Deadlines are plan-specific. The table summarizes common federal frameworks cited on many notices. Your adverse benefit determination letter controls filing dates and channels.

Plan type	Internal appeal	External review	Urgent / expedited
ACA marketplace / fully insured individual & small group	Often 60–180 days from the adverse determination (check notice). ACA internal claims and appeals rules require written notice of rights.	After exhausting internal appeals, many enrollees may request external review; federal rules set minimum external review rights for qualifying plans (see 45 CFR 147.136).	Urgent medical situations may qualify for expedited review; many plans must respond within 72 hours when delay could seriously jeopardize health (45 CFR 147.136(b)(3) framework).
Self-funded employer plan (ERISA)	29 CFR 2560.503-1 requires a reasonable opportunity for a full and fair review; many plans allow about 180 days to request review of an adverse benefit determination unless the plan document grants longer.	External review rights depend on plan design and state law for insured portions; many ERISA plans use independent review vendors after internal exhaustion.	Expedited review must be available when the timeframe for a standard review could seriously jeopardize life or health (29 CFR 2560.503-1(h)(3)(i)).
Original Medicare (Part A & B)	Medicare uses redetermination (Level 1) by the Medicare Administrative Contractor — typically 120 days from the date of the initial determination on the MSN.	Reconsideration (Level 2), ALJ hearing, and further levels follow CMS Medicare appeals guidance — not the same clocks as commercial insurance.	Expedited Medicare determinations exist for certain hospital and SNF situations; follow instructions on the MSN.
Medicare Advantage (Part C)	Organization determination and plan-level appeals follow CMS Medicare Advantage rules; use the plan's forms and clocks on the denial.	After plan-level appeals, enrollees may request CMS review or, for some issues, state external review when applicable.	Part C plans must offer expedited reviews for urgent requests per CMS marketing/appeals requirements.
Medicare Part D (prescription drugs)	Coverage determinations and exceptions use PBM/plan Part D forms; standard determination timeframes are set in CMS Part D regulations.	Appeal to the Independent Review Entity (IRE) after plan-level denial of a standard or expedited determination.	Expedited exceptions and appeals exist when waiting could seriously harm health; request expedited processing in writing.
Medicaid / CHIP (state)	Each state Medicaid agency sets fair hearing and appeal timelines; use the notice from your managed care plan or state agency.	State fair hearing after managed care appeal exhaustion; timelines vary by state and benefit type.	Many states allow expedited hearings when delay would jeopardize health; cite urgency on the request form.

Cite 29 CFR 2560.503-1 for many ERISA group health plans and 45 CFR 147.136 for many non-grandfathered individual/small group plans. Medicare and Medicaid use separate statutes and forms.

Documents to gather

Denial letter / EOB with reason code
Prescriber notes and BMI documentation
Comorbidity list and relevant labs
Failed or contraindicated prior therapies with dates
Plan clinical policy or formulary page if you have it
Signed letter of medical necessity from the prescribing clinician

Use the deadline on your denial notice. Do not assume 180 days. Medicare Part D coverage determinations and Medicaid have separate rules.

Weak vs strong wording

Weak

I need Wegovy because I have tried to lose weight and my insurance should cover FDA-approved drugs.

Stronger

Member meets [plan policy] BMI and comorbidity criteria. Phentermine trial 3/2025–6/2025 stopped for [adverse effect]. Prescriber attests metformin is contraindicated due to [reason]. Request coverage of Wegovy 2.4 mg per labeled indication.

Reviewers look for policy criteria and a therapy history, not a general fairness argument.

Weak

My doctor says I need Zepbound and the plan should approve it.

Stronger

Denial cites step therapy requiring [preferred drug]. Member completed 12-week trial of [drug] with <3% weight loss (chart notes attached). BMI 34.2 with obstructive sleep apnea (ICD-10 attached). Request step-therapy exception and coverage of Zepbound per plan policy section [X].

Step-therapy appeals need documented trial outcomes and the plan policy section cited on the denial.

Weak

Ozempic is the same as Wegovy so please cover it for weight loss.

Stronger

Prescription is for semaglutide 2.4 mg for chronic weight management (ICD-10 E66.x). Denial reason: non-formulary. Request formulary exception because member meets BMI/comorbidity criteria and preferred alternatives are contraindicated or previously failed.

Match the billed indication and denial reason; do not swap drugs or indications without clinical support.

Common mistakes

Appealing Ozempic for weight loss when the denial is a diabetes prior authorization. Use the indication the prescriber billed.
Skipping the required step-therapy drug without documenting failure, intolerance, or contraindication
Missing the PBM vs medical-benefit split. Some GLP-1s are pharmacy benefits and appeals go to the PBM, not the medical-claims address.
Submitting a patient letter without prescriber chart notes that support BMI, comorbidities, and prior trials

What to do next

Save proof of filing (portal screenshot, fax confirmation, or certified mail receipt).
If the plan requests more records, respond within the timeframe on the follow-up letter.
When internal appeals are exhausted, read your notice for external review or state complaint rights.
Need deadlines, evidence lists, and filing checklists in one download? Consider the matching AppealFlow pack on the pricing page (document prep only).
Optional paid pack: Appeal Pack (document preparation only).

Authoritative sources

Related tools and guides

FAQs

Generate your GLP-1 appeal letter with the tool above, attach chart notes, and file before the date on your denial letter.

Free draft tool · Review with your clinician · Not legal or medical advice · Disclaimer